|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Cara Therapeutics (NASDAQ: CARA) through any online brokerage.
The latest price target for Cara Therapeutics (NASDAQ: CARA) was reported by HC Wainwright & Co. on August 24, 2021. The analyst firm set a price target for 35.00 expecting CARA to rise to within 12 months (a possible 113.15% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Cara Therapeutics (NASDAQ: CARA) is $16.42 last updated Wed Oct 27 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Cara Therapeutics.
Cara Therapeutics’s $Q3 earnings are confirmed for after-market on $November 8, 2021.
There is no upcoming split for Cara Therapeutics.
Cara Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.